Agreement signedPublished 24 Aug 2026
Skye Bioscience, Inc. /
Redx Pharma Limited
Skye Bioscience, Inc. signed an agreement for Redx Pharma Limited.




01 / BuyerSkye Bioscience, Inc.
02 / TargetRedx Pharma Limited
Source for the buyer and target: Skye Bioscience, Inc.
For the buyer and target.
“In connection with the proposed acquisition of Redx Pharma Limited (“Redx”) by Skye Bioscience, Inc. (“Skye” or the “Company”) (the “Transaction”), the Company intends to file with the U.S. Securities and Exchange Commission (the “SEC”) a proxy statement (the “Proxy Statement”), the definitive version of which will be sent or provided to the Company’s stockholders.”
Published 24 Aug 2026
Open the sourceWhat happened
The deal for Redx Pharma Limited is signed, with Skye Bioscience, Inc. as the buyer. [01]
The filing from Skye Bioscience, Inc. is dated Aug. 24, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
01
Source · Skye Bioscience, Inc.
Skye Bioscience, Inc. signed an agreement for Redx Pharma Limited.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly